|Articles|June 7, 2016
CMU Research Validates Improved Clinical Trial Processes
ICON plc announces the results of research evaluating patient-centric and patient-designed informed consent formats from Carnegie Mellon University.
Advertisement
ICON plc announces the results of research evaluating patient-centric and patient-designed informed consent formats from Carnegie Mellon University. The results show that patient consent forms could be shortened without losing understanding or required content.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Patient Recruitment in Clinical Trials: Why the Industry's Longstanding Approach Is No Longer Fit for Purpose
2
Precision Oncology Trials Need to Reflect the Complexity of Cancer Biology
3
ACT Brief: Portfolio-Level Recruitment Strategy, Structural Change Through Systems Thinking, and Kidney Function Preservation in IgAN
4
ACT Brief: Local-First Communication Design, RBQM Financial Impact, and First Oral PCSK9 Inhibitor
5